United Therapeutics Gets Legal Win in Patent Litigation Against Liquidia

Dow Jones

6 hours ago

United Therapeutics notched a legal win in its patent lawsuit against Liquidia as a federal judge denied Liquidia's motion to block a portion of its legal claims.

Liquidia had motioned to strike part of United Therapeutics' argument that relied on the "common ownership exception," a rule in patent law preventing a new patent from being invalidated based on an earlier patent owned by the same entity. Judge Richard Andrews of the U.S. District Court for the District of Delaware on Wednesday denied Liquidia's motion.

Shares of United Therapeutics were up 13% at $541.68 as of midday Wednesday. Liquidia shares fell 25% to $53.22.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/2672789378"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2672789378\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2672789378?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-01 00:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2672789378","market":"fut","top_or_hot":-1,"title":"United Therapeutics Gets Legal Win in Patent Litigation Against Liquidia","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  United <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> notched a legal win in its patent lawsuit against Liquidia as a federal judge denied Liquidia's motion to block a portion of its legal claims. \n</p>\n<p>\n  Liquidia had motioned to strike part of United Therapeutics' argument that relied on the \"common ownership exception,\" a rule in patent law preventing a new patent from being invalidated based on an earlier patent owned by the same entity. Judge Richard Andrews of the U.S. District Court for the District of <a href=\"https://laohu8.com/S/VMM\">Delaware</a> on Wednesday denied Liquidia's motion. \n</p>\n<p>\n  Shares of United Therapeutics were up 13% at $541.68 as of midday Wednesday. Liquidia shares fell 25% to $53.22. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>United Therapeutics Gets Legal Win in Patent Litigation Against Liquidia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnited Therapeutics Gets Legal Win in Patent Litigation Against Liquidia\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-10-01 00:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  United <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> notched a legal win in its patent lawsuit against Liquidia as a federal judge denied Liquidia's motion to block a portion of its legal claims. \n</p>\n<p>\n  Liquidia had motioned to strike part of United Therapeutics' argument that relied on the \"common ownership exception,\" a rule in patent law preventing a new patent from being invalidated based on an earlier patent owned by the same entity. Judge Richard Andrews of the U.S. District Court for the District of <a href=\"https://laohu8.com/S/VMM\">Delaware</a> on Wednesday denied Liquidia's motion. \n</p>\n<p>\n  Shares of United Therapeutics were up 13% at $541.68 as of midday Wednesday. Liquidia shares fell 25% to $53.22. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UTHR","symbol_name":"美国联合医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2672789378","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2672789378","pubTimestamp":1790787420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"United Therapeutics notched a legal win in its patent lawsuit against Liquidia as a federal judge denied Liquidia's motion to block a portion of its legal claims.Liquidia had motioned to strike part of United Therapeutics' argument that relied on the \"common ownership exception,\" a rule in patent law preventing a new patent from being invalidated based on an earlier patent owned by the same entity. Judge Richard Andrews of the U.S. District Court for the District of Delaware on Wednesday denied Liquidia's motion.Shares of United Therapeutics were up 13% at $541.68 as of midday Wednesday. Liquidia shares fell 25% to $53.22.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"UTHR":"美国联合医疗","USRD":"THEMES US R&D CHAMPIONS ETF","LQDA":"Liquidia Technologies Inc","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","BK4139":"生物科技","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","BK4532":"文艺复兴科技持仓","BK4007":"制药"},"translate_title":"United Therapeutics 在针对 Liquidia 的专利诉讼中取得法律胜利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UTHR":1.5,"USRD":0.84,"LQDA":0.9},"content_text":"United Therapeutics notched a legal win in its patent lawsuit against Liquidia as a federal judge denied Liquidia's motion to block a portion of its legal claims. \n\n\n  Liquidia had motioned to strike part of United Therapeutics' argument that relied on the \"common ownership exception,\" a rule in patent law preventing a new patent from being invalidated based on an earlier patent owned by the same entity. Judge Richard Andrews of the U.S. District Court for the District of Delaware on Wednesday denied Liquidia's motion. \n\n\n  Shares of United Therapeutics were up 13% at $541.68 as of midday Wednesday. Liquidia shares fell 25% to $53.22.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}